Argatroban Injection, Solution
Product Images NDC 25021-414

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Argatroban (NDC 25021-414). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Arg06 0000 01)

FDA Label Image

Figure 1 (Arg06 0000 02)

FDA Label Image

Figure 2 (Arg06 0000 03)

FDA Label Image

Figure 3 (Arg06 0000 04)

FDA Label Image

Figure 4 (Arg06 0000 05)

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Arg06 0000 06)

Package Label – Principal Display Panel – Vial Label (Arg06 0000 06)
NDC 25021-414-50 is a medication containing Argatroban, which is an injection with a concentration of 50mg per 50ml (1mg per mL) used for anticoagulation during medical procedures. The text also mentions a lot number.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.